ADHD Institute Logo
Takeda Logo
Burger Menu
Burger Menu
ADHD Institute Register
Burden of ADHD
Assessment & diagnosis
Disease management
Meetings & events
Publications 2022
Home
Home
Burden of ADHD
Burden of ADHD
  • Epidemiology
  • Comorbidities
  • Aetiology
  • Impact of ADHD
  • Assessment & diagnosis
    Assessment & diagnosis
  • Symptoms of ADHD
  • Diagnosis
  • Assessment
  • Rating scales
  • Disease management
    Disease management
  • Guidelines
    • ADHD clinical guidelines
    • CADDRA guidelines
    • German guidelines
    • NICE guidelines
    • Spanish guidelines
  • Optimal management of ADHD
  • Transition in ADHD
  • Non-pharmacological therapy
  • Pharmacological therapy
  • Meetings & events
    Meetings & events
  • ADHD Institute meetings
    • Week 1 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Week 2 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Week 3 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Week 4 ‒ ADHD and comorbid mental health conditions across the lifespan
  • Congress reports
    • 33rd European Clinical Neuropsychopharmacology (ECNP) Virtual Congress
    • 28th European Congress of Psychiatry (EPA) Virtual Congress
  • Key congresses 2022
  • Publications 2022
    Publications 2022
  • Publications 2021
  • Publications 2020
  • Burden of ADHD

    Epidemiology

    Comorbidities

    Aetiology

    Impact of ADHD

    Video: Persistence of ADHD from childhood to adulthood

    Animation: Childhood/Adolescent ADHD and the brain

    Animation: Adult ADHD and the brain

    Animation: Childhood/Adolescent ADHD and the brain

    Animation: Adult ADHD and the brain

    Video: Persistence of ADHD from childhood to adulthood

    Animation: Childhood/Adolescent ADHD and the brain

    Animation: Adult ADHD and the brain

    Video: Persistence of ADHD from childhood to adulthood

    Video: Persistence of ADHD from childhood to adulthood

    Animation: Childhood/Adolescent ADHD and the brain

    Animation: Adult ADHD and the brain

    Assessment & diagnosis

    Symptoms of ADHD

    Diagnosis

    Assessment

    Rating scales

    Video: How do the symptoms of ADHD change across the lifespan?

    Video: Who are the key specialists you collaborate with in your clinical practice?

    eLearning: Rating Scales

    Video: Who are the key specialists you collaborate with in your clinical practice?

    eLearning: Rating Scales

    Video: How do the symptoms of ADHD change across the lifespan?

    Video: Who are the key specialists you collaborate with in your clinical practice?

    eLearning: Rating Scales

    Video: How do the symptoms of ADHD change across the lifespan?

    eLearning: Rating Scales

    Video: How do the symptoms of ADHD change across the lifespan?

    Video: Who are the key specialists you collaborate with in your clinical practice?

    Disease management

    Guidelines

    Optimal management of ADHD

    Transition in ADHD

    Non-pharmacological therapy

    Pharmacological therapy

    ADHD clinical guidelines

    An interactive guide to the MOA of selected medications used in the treatment of ADHD

    Animation: Childhood/Adolescent ADHD and treatment effects in the brain

    ADHD clinical guidelines

    CADDRA guidelines

    German guidelines

    NICE guidelines

    Spanish guidelines

    An interactive guide to the MOA of selected medications used in the treatment of ADHD

    Animation: Childhood/Adolescent ADHD and treatment effects in the brain

    ADHD clinical guidelines

    VIDEO: ‘Lost in transition’ in adulthood

    Animation: Childhood/Adolescent ADHD and treatment effects in the brain

    Animation: Childhood/Adolescent ADHD and treatment effects in the brain

    ADHD Clinical Guidelines

    An interactive guide to the MOA of selected medications used in the treatment of ADHD

    ADHD clinical guidelines

    Video: How can we improve transition

    An interactive guide to the MOA of selected medications used in the treatment of ADHD

    ADHD Clinical Guidelines

    Video: Optimising transition: Bridging the gap in clinical practice

    VIDEO: ‘Lost in transition’ in adulthood

    Meetings & events

    Congress reports

    ADHD Institute meetings

    Key congresses 2022

    ADHD Institute meetings

    Congress reports

    ADHD Institute meetings

    33rd European Clinical Neuropsychopharmacology (ECNP) Virtual Congress

    28th European Congress of Psychiatry (EPA) Virtual Congress

    Meetings & events

    Congress reports

    ADHD Institute meetings

    Congress reports

    Publications 2022

    Publications 2021

    Publications 2020

    Publications 2021

    Publications 2020

    Search

    Contact us

    Privacy notice

    Terms of use

    Takeda in ADHD

    Sitemap

    ADHD resources developed by Takeda

    • Home
    • Burden of ADHD
    • Epidemiology
    • Comorbidities
    • Aetiology
    • Impact of ADHD
    • Assessment & diagnosis
    • Symptoms of ADHD
    • Diagnosis
    • Assessment
    • Rating scales
    • Disease management
    • Guidelines
    • ADHD clinical guidelines
    • CADDRA guidelines
    • German guidelines
    • NICE guidelines
    • Spanish guidelines
    • Optimal management of ADHD
    • Transition in ADHD
    • Non-pharmacological therapy
    • Pharmacological therapy
    • Meetings & events
    • Congress reports
    • 33rd European Clinical Neuropsychopharmacology (ECNP) Virtual Congress
    • 28th European Congress of Psychiatry (EPA) Virtual Congress
    • ADHD Institute meetings
    • Week 1 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Week 2 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Week 3 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Week 4 ‒ ADHD and comorbid mental health conditions across the lifespan
    • Key congresses 2022
    • Publications 2022
    • Publications 2021
    • Publications 2020
    Facebook Google LinkedIn Pinterest Twitter

    Social and economic costs of ADHD

    Home | Publications 2020 |
    Takeda Logo
    • Burden of ADHD
    • Assessment & diagnosis
    • Disease management
    • Meetings & events
    • Publications 2022
    • Takeda in ADHD
    • Contact us
    • Terms of use
    • Privacy notice
    • Sitemap
    © 2023 Takeda Pharmaceutical Company Limited. All rights reserved
    Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical and Company Limited.
    All trademarks are the property of their respective owners
    This website is intended for healthcare professionals outside the US and UK only.
    Site last updated: January 2022 - Main website content job code: C-ANPROM/EUC/NBU/0001

    ADHD Institue logo

    You’re now being transferred to

    and are leaving the ADHD Institute site

    Takeda has no influence or control over the content of this third party website.

    Continue Cancel